US Edition
EuroPCR 2025: Search for suitable candidates for cerebral embolic protection continues - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
EuroPCR 2025: Search for suitable candidates for cerebral embolic protection continues - Cardiovascular News
A pooled, individual patient-level data meta-analysis of two trials investigating the use of the Sentinel (Boston Scientific) cerebral embolic protection device has found no evidence of a reduction in stroke when the device is routinely used during transcatheter aortic valve implantation (TAVI). The analysis of the PROTECTED TAVR and BHF PROTECT TAVI trials, presented during a late-breaking trial session at EuroPCR 2025 (20–23 May, Paris, France…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
